scispace - formally typeset
Y

Yawen Ding

Researcher at Nanjing University

Publications -  11
Citations -  309

Yawen Ding is an academic researcher from Nanjing University. The author has contributed to research in topics: Chemistry & Metastasis. The author has an hindex of 4, co-authored 7 publications receiving 149 citations.

Papers
More filters
Journal ArticleDOI

Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects.

TL;DR: A reactive oxygen species (ROS) responsive nanoplatform is reported to successfully add up tumor oxygenation and HIF-1 functional inhibition and achieve synergistically the optimal inhibition of tumor growth.
Journal ArticleDOI

Copper-Based Nanoscale Coordination Polymers Augmented Tumor Radioimmunotherapy for Immunogenic Cell Death Induction and T-Cell Infiltration.

TL;DR: In this paper, the authors constructed a Cu-based nanoscale coordination polymers (NCPs) with mixed-valence (Cu+ /Cu2+ ), which can simultaneously and independently induce the generation of Cu+ -triggered hydroxyl radicals and Cu2+ -driven GSH elimination, to synergize with radiation therapy for potent ICD induction.
Journal ArticleDOI

Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species

TL;DR: Wang et al. as mentioned in this paper encapsulated one of the most effective HIF-1 inhibitors, acriflavine (ACF), and DOX in liposomes (DOX-ACF@Lipo) to construct a bifunctional liposome.
Journal ArticleDOI

Oxygen-rich chemotherapy via modified Abraxane to inhibit the growth and metastasis of triple-negative breast cancer.

TL;DR: Oxygen-rich chemotherapy was realized to efficiently sensitize paclitaxel, relieve acquired resistance and inhibit tumor metastasis, and results in about a 2-fold increase in inhibition efficiency of tumor growth in both primary and metastatic tumors compared with traditional Abx therapy.
Journal ArticleDOI

Novel copper-based and pH-sensitive nanomedicine for enhanced chemodynamic therapy

TL;DR: This work utilized albumin as a reducing agent to establish novel copper-based and pH-sensitive nanocarrier CuNPs with abundant Cu+, which can encapsulate histone deacetylase (HDAC) inhibitor vorinostat to form uniform and stable nanomedicine V-CuNPs for synergistic chromatin remodelling and chemodynamic therapy.